Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake

Bergh Marianne Skov-Skov, Bogen Inger Lise, Vevelstad Merete, Øiestad Åse Marit Leere

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (33)

  1. Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis 2025-01-01 · Expand citations
  2. National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022. 2024-05-01 · Expand citations
  3. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin 2024-04-29 · Expand citations
  4. Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS) 2024-03-01 · Expand citations
  5. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. 2023-10-01 · Expand citations
  6. Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. 2023-04-01 · Expand citations
  7. A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS. 2022-07-14 · Expand citations
  8. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. 2022-05-01 · Expand citations
  9. Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects. 2022-04-01 · Expand citations
  10. Dose-response relationships of psilocybin-induced subjective experiences in humans. 2021-04-01 · Expand citations
  11. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma 2021-02-01 · Expand citations
  12. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
  13. Biological Effects and Biodistribution of Bufotenine on Mice. 2018-01-01 · Expand citations
  14. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
  15. Synthesis, hydrolysis and stability of psilocin glucuronide 2014-04-01 · Expand citations
  16. Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS 2013-05-01 · Expand citations
  17. A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability 2012-11-01 · Expand citations
  18. Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases 2010-03-01 · Expand citations
  19. Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user 2006-07-01 · Expand citations
  20. Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography 2006-04-01 · Expand citations
  21. Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples 2003-11-01 · Expand citations
  22. Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man 2002-09-01 · Expand citations
  23. Detection of psilocin in body fluids 2000-09-01 · Expand citations
  24. Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction 1998-05-01 · Expand citations
  25. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
  26. 10.1016/0024-3205(76)90441-0
  27. 10.1016/0165-1781(95)02747-k
  28. 10.1016/j.fsir.2023.100336
  29. 10.1016/j.talo.2022.100171
  30. 10.1080/00365510510013604
  31. 10.1080/02791072.1996.10472488
  32. 10.1177/0004563214554842
  33. 10.3390/ijms21239279

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.